ARTICLE | Company News
ReGenX Biosciences LLC, Voyager Therapeutics Inc. deal
June 9, 2014 7:00 AM UTC
ReGenX granted Voyager a non-exclusive, worldwide license to NAV vector technology for development and commercialization of gene therapies to treat amyotrophic lateral sclerosis (ALS), Friedreich's at...